ijerph-logo

Journal Browser

Journal Browser

COVID-19: Prevention, Diagnosis, Therapy and Follow Up

A special issue of International Journal of Environmental Research and Public Health (ISSN 1660-4601). This special issue belongs to the section "Global Health".

Deadline for manuscript submissions: closed (31 January 2021) | Viewed by 109536

Special Issue Editors


E-Mail Website
Guest Editor
Dipartimento di Medicina clinica e Chirurgia, Università degli Studi di Napoli Federico II, 80131 Naples, Italy
Interests: COVID-19; bacterial and fungal infections, antibiotics, HIV and AIDS, HCV, HBV
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Clinical Medicine and Surgery, Federico II University of Naples, Via Pansini5, Naples, 81100 Italy
Interests: endocrinology; epidemiology; preventive medicine; precision medicine; predictive medicine; rare diseases; environmental pollution

Special Issue Information

Dear Colleagues,

Covid-19 pandemic is dramatically impacting population and healthcare systems across the world. Many issues concern COVID-19 prevention of the contagion, symptoms, underlying factors or concurrent conditions that can predispose people to the infection, diagnosis and early diagnostic tools, treatment protocols, and follow up of healed people. A lot of emerging evidences have already been published concerning the effect of SARS-COV-2 infection on almost any human organ, and clinical experiences are going everywhere in order to cope with this incredible threat to human health.

This special issue on COVID-19: Prevention, Diagnosis, Therapy and Follow Up is aimed at stimulating clinicians and researchers working in the field of indfectious diseases, virology, epidemiology, preventive medicine and public health, internal medicine, pulmonology, radiology, neurology, cardiology etc. to share their experiences with the scientific community, in the perspective of common advance of knowledge that will lead us out from this health emergency.

Articles addressing exposure to the virus, biological mechanisms, treatment protocols, follow up, as well as epidemiological surveys are solicited: systematic reviews, meta-analyses, original research articles, short articles or commentaries are welcome and expected to add relevant information to the current knowledge.

Prof. Dr. Ivan Gentile
Dr. Annamaria Colao
Dr. Prisco Piscitelli
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Environmental Research and Public Health is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2500 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • COVID-19
  • Epidemiology
  • Prevention
  • Diagnosis
  • Treatment
  • Follow-up

Published Papers (18 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Editorial

Jump to: Research, Review

3 pages, 249 KiB  
Editorial
COVID-19: Time for Post-Exposure Prophylaxis?
by Ivan Gentile, Alberto Enrico Maraolo, Prisco Piscitelli and Annamaria Colao
Int. J. Environ. Res. Public Health 2020, 17(11), 3997; https://doi.org/10.3390/ijerph17113997 - 04 Jun 2020
Cited by 8 | Viewed by 4030
Abstract
From a healthcare perspective, infection due to the novel coronavirus SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) and the ensuing syndrome called COVID-19 (coronavirus disease 2019) represents the biggest challenge the world has faced in several decades. Particularly worrisome are the high contagiousness [...] Read more.
From a healthcare perspective, infection due to the novel coronavirus SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) and the ensuing syndrome called COVID-19 (coronavirus disease 2019) represents the biggest challenge the world has faced in several decades. Particularly worrisome are the high contagiousness of the virus and the saturation of hospitals’ capacity due to overwhelming caseloads. Non-pharmaceutical interventions such as quarantine and inter-personal distancing are crucial to limiting the spread of the virus in the general population, but more tailored interventions may be needed at an individual level on a case-by-case basis. In this perspective, the most insidious situation is when an individual has contact with a contagious subject without adequate protection. If rapidly recognized afterwards, this occurrence may be promptly addressed through a post-exposure chemoprophylaxis (PEP) with antiviral drugs. This strategy has been implemented for other respiratory viruses (influenza above all) and was successfully used in South Korea among healthcare workers against the Middle East respiratory syndrome (MERS) coronavirus, by providing people who were exposed to high-risk contacts with lopinavir-ritonavir plus ribavirin. Initial experiences with the use of hydroxychloroquine to prevent COVID-19 also seem promising. Post-exposure chemoprophylaxis might help mitigate the spread of SARS-CoV-2 in the current phase of the COVID-19 pandemic. Full article
(This article belongs to the Special Issue COVID-19: Prevention, Diagnosis, Therapy and Follow Up)

Research

Jump to: Editorial, Review

22 pages, 6012 KiB  
Article
Interaction of Pelargonium sidoides Compounds with Lactoferrin and SARS-CoV-2: Insights from Molecular Simulations
by Federico Iacovelli, Gaetana Costanza, Alice Romeo, Terenzio Cosio, Caterina Lanna, Antonino Bagnulo, Umberto Di Maio, Alice Sbardella, Roberta Gaziano, Sandro Grelli, Ettore Squillaci, Alessandro Miani, Prisco Piscitelli, Luca Bianchi, Mattia Falconi and Elena Campione
Int. J. Environ. Res. Public Health 2022, 19(9), 5254; https://doi.org/10.3390/ijerph19095254 - 26 Apr 2022
Cited by 5 | Viewed by 3032
Abstract
(1) Background: Pelargonium sidoides extracts and lactoferrin are two important natural, anti-inflammatory, and antiviral agents, which can interfere with the early stages of SARS-CoV-2 infection. Molecular docking and molecular dynamics simulation approaches have been applied to check for the occurrence of interactions of [...] Read more.
(1) Background: Pelargonium sidoides extracts and lactoferrin are two important natural, anti-inflammatory, and antiviral agents, which can interfere with the early stages of SARS-CoV-2 infection. Molecular docking and molecular dynamics simulation approaches have been applied to check for the occurrence of interactions of the Pelargonium sidoides compounds with lactoferrin and with SARS-CoV-2 components. (2) Methods: Computational methods have been applied to confirm the hypothesis of a direct interaction between PEL compounds and the lactoferrin protein and between Pelargonium sidoides compounds and SARS-CoV-2 Spike, 3CLPro, RdRp proteins, and membrane. Selected high-score complexes were structurally investigated through classical molecular dynamics simulation, while the interaction energies were evaluated using the molecular mechanics energies combined with generalized Born and surface area continuum solvation method. (3) Results: Computational analyses suggested that Pelargonium sidoides extracts can interact with lactoferrin without altering its structural and dynamical properties. Furthermore, Pelargonium sidoides compounds should have the ability to interfere with the Spike glycoprotein, the 3CLPro, and the lipid membrane, probably affecting the functional properties of the proteins inserted in the double layer. (4) Conclusion: Our findings suggest that Pelargonium sidoides may interfere with the mechanism of infection of SARS-CoV-2, especially in the early stages. Full article
(This article belongs to the Special Issue COVID-19: Prevention, Diagnosis, Therapy and Follow Up)
Show Figures

Figure 1

12 pages, 1333 KiB  
Article
Burnout Impact of COVID-19 Pandemic on Health-Care Professionals at Assiut University Hospitals, 2020
by Shimaa A. Elghazally, Atef F. Alkarn, Hussein Elkhayat, Ahmed K. Ibrahim and Mariam Roshdy Elkhayat
Int. J. Environ. Res. Public Health 2021, 18(10), 5368; https://doi.org/10.3390/ijerph18105368 - 18 May 2021
Cited by 37 | Viewed by 5382
Abstract
Background: burnout syndrome is a serious and growing problem among medical staff. Its adverse outcomes not only affect health-care providers’ health, but also extend to their patients, resulting in bad-quality care. The COVID-19 pandemic puts frontline health-care providers at greater risk of psychological [...] Read more.
Background: burnout syndrome is a serious and growing problem among medical staff. Its adverse outcomes not only affect health-care providers’ health, but also extend to their patients, resulting in bad-quality care. The COVID-19 pandemic puts frontline health-care providers at greater risk of psychological stress and burnout syndrome. Objectives: this study aimed to identify the levels of burnout among health-care professionals currently working at Assiut University hospitals during the COVID-19 pandemic. Methods: the current study adopted an online cross-sectional design using the SurveyMonkey® website for data collection. A total of 201 physicians were included and the Maslach Burnout Inventory (MBI) scale was used to assess the three burnout syndrome dimensions: emotional exhaustion, depersonalization, and reduced personal accomplishment. Results: about one-third, two-thirds, and one-quarter of the respondents had high emotional exhaustion, high depersonalization, and low personal accomplishment, respectively. Younger, resident, and single physicians reported higher burnout scores. The personal accomplishment score was significantly higher among males. Those working more than eight hours/day and dealing with COVID-19 patients had significantly higher scores. Conclusion: during the COVID-19 pandemic, a high prevalence of burnout was recorded among physicians. Age, job title, working duration, and working hours/day were significant predictors for burnout syndrome subscale results. Preventive and interventive programs should be applied in health-care organizations during pandemics. Full article
(This article belongs to the Special Issue COVID-19: Prevention, Diagnosis, Therapy and Follow Up)
Show Figures

Figure 1

11 pages, 2126 KiB  
Article
Investigation of Nasal/Oropharyngeal Microbial Community of COVID-19 Patients by 16S rDNA Sequencing
by Martina Rueca, Andrea Fontana, Barbara Bartolini, Pierluca Piselli, Antonio Mazzarelli, Massimiliano Copetti, Elena Binda, Francesco Perri, Cesare Ernesto Maria Gruber, Emanuele Nicastri, Luisa Marchioni, Giuseppe Ippolito, Maria Rosaria Capobianchi, Antonino Di Caro and Valerio Pazienza
Int. J. Environ. Res. Public Health 2021, 18(4), 2174; https://doi.org/10.3390/ijerph18042174 - 23 Feb 2021
Cited by 50 | Viewed by 4512
Abstract
Since December 2019, SARS-CoV-2 infection has been still rapidly spreading, resulting in a pandemic, followed by an increasing number of cases in countries throughout the world. The severity of the disease depends on the patient’s overall medical condition but no appropriate markers are [...] Read more.
Since December 2019, SARS-CoV-2 infection has been still rapidly spreading, resulting in a pandemic, followed by an increasing number of cases in countries throughout the world. The severity of the disease depends on the patient’s overall medical condition but no appropriate markers are available to establish the prognosis of the patients. We performed a 16S rRNA gene sequencing, revealing an altered composition of the nasal/oropharyngeal (NOP) microbiota in 21 patients affected by COVID-19, paucisymptomatic or in an Intensive Care Unit (ICU), as compared to 10 controls negative for COVID-19 or eight affected by a different Human Coronavirus (HKU, NL63 and OC43). A significant decrease in Chao1 index was observed when patients affected by COVID-19 (in ICU) were compared to paucisymptomatic. Furthermore, patients who were in ICU, paucisymptomatic or affected by other Coronaviruses all displayed a decrease in the Chao1 index when compared to controls, while Shannon index significantly decreased only in patients under ICU as compared to controls and paucisymptomatic patients. At the phylum level, Deinococcus-Thermus was present only in controls as compared to SARS-CoV-2 patients admitted to ICU, paucisymptomatic or affected by other coronaviruses. Candidatus Saccharibacteria (formerly known as TM7) was strongly increased in negative controls and SARS-CoV-2 paucisymptomatic patients as compared to SARS-CoV-2 ICU patients. Other modifications were observed at a lower taxonomy level. Complete depletion of Bifidobacterium and Clostridium was exclusively observed in ICU SARS-CoV-2 patients, which was the only group characterized by the presence of Salmonella, Scardovia, Serratia and Pectobacteriaceae. In conclusion, our preliminary results showed that nasal/oropharyngeal microbiota profiles of patients affected with SARS-CoV-2 may provide valuable information in order to facilitate the stratification of patients and may open the way to new interventional strategies in order to ameliorate the outcome of the patients. Full article
(This article belongs to the Special Issue COVID-19: Prevention, Diagnosis, Therapy and Follow Up)
Show Figures

Figure 1

10 pages, 596 KiB  
Article
Serum KL-6 Could Represent a Reliable Indicator of Unfavourable Outcome in Patients with COVID-19 Pneumonia
by Riccardo Scotto, Biagio Pinchera, Francesco Perna, Lidia Atripaldi, Agnese Giaccone, Davide Sequino, Emanuela Zappulo, Alessia Sardanelli, Nicola Schiano Moriello, Anna Stanziola, Marialuisa Bocchino, Ivan Gentile and Alessandro Sanduzzi
Int. J. Environ. Res. Public Health 2021, 18(4), 2078; https://doi.org/10.3390/ijerph18042078 - 20 Feb 2021
Cited by 22 | Viewed by 2905
Abstract
KL-6 is a sialoglycoprotein antigen which proved elevated in the serum of patients with different interstitial lung diseases, especially in those with a poorer outcome. Given that interstitial pneumonia is the most common presentation of SARS-CoV2 infection, we evaluated the prognostic role of [...] Read more.
KL-6 is a sialoglycoprotein antigen which proved elevated in the serum of patients with different interstitial lung diseases, especially in those with a poorer outcome. Given that interstitial pneumonia is the most common presentation of SARS-CoV2 infection, we evaluated the prognostic role of KL-6 in patients with COVID-19 pneumonia. Patients with COVID-19 pneumonia were prospectively enrolled. Blood samples were collected at the time of enrolment (TOE) and on day 7 (T1). Serum KL-6 concentrations were measured by chemiluminescence enzyme immunoassay using a KL-6 antibody kit (LUMIPULSE G1200, Fujirebio) and the cut-off value was set at >1000 U/mL. Fifteen out of 34 enrolled patients (44.1%) died. Patients with unfavourable outcome showed significantly lower P/F ratio and higher IL-6 values and plasmatic concentrations of KL-6 at TOE compared with those who survived (median KL-6: 1188 U/mL vs. 260 U/mL, p < 0.001). KL-6 > 1000 U/mL resulted independently associated with death (aOR: 11.29, p < 0.05) with a positive predictive value of 83.3%. Our results suggest that KL-6 is a reliable indicator of pulmonary function and unfavourable outcome in patients with COVID-19 pneumonia. A KL-6 value > 1000 U/mL resulted independently associated with death and showed good accuracy in predicting a poorer outcome. KL-6 may thus represent a quick, inexpensive, and sensitive parameter to stratify the risk of severe respiratory failure and death. Full article
(This article belongs to the Special Issue COVID-19: Prevention, Diagnosis, Therapy and Follow Up)
Show Figures

Figure 1

13 pages, 1027 KiB  
Article
The Professional and Psycho-Emotional Impact of the COVID-19 Pandemic on Medical Care—A Romanian GPs’ Perspective
by Celina Silvia Stafie, Lenuta Profire, Maria Manuela Apostol and Irina Iuliana Costache
Int. J. Environ. Res. Public Health 2021, 18(4), 2031; https://doi.org/10.3390/ijerph18042031 - 19 Feb 2021
Cited by 4 | Viewed by 3097
Abstract
The aim of this study was to assess the psycho-emotional impact and the adjustment degree of Romanian general practitioners (GPs) in the coronavirus disease 2019 (COVID-19) pandemic context. With a cross-sectional design, the study included 677 GPs to whom a validated questionnaire based [...] Read more.
The aim of this study was to assess the psycho-emotional impact and the adjustment degree of Romanian general practitioners (GPs) in the coronavirus disease 2019 (COVID-19) pandemic context. With a cross-sectional design, the study included 677 GPs to whom a validated questionnaire based on different items targeting three factors was sent: burden of prevention, presence of stress symptoms, and adjustment to pandemic. The burden of prevention and the adjustment effort to the pandemic were felt significantly more by female doctors and by GPs working in associated offices. The case definition quality, the support received, the professional life changes, and the stress symptoms proved to be the main predictors for the adjustment to pandemic. The adjustment measurement questionnaire can be used in further studies to identify the most supportive public health practices in difficult epidemiological contexts. Full article
(This article belongs to the Special Issue COVID-19: Prevention, Diagnosis, Therapy and Follow Up)
Show Figures

Figure 1

15 pages, 1135 KiB  
Article
Clinical Profile, Treatment and Predictors during the First COVID-19 Wave: A Population-Based Registry Analysis from Castile and Leon Hospitals
by Eduardo Gutiérrez-Abejón, Eduardo Tamayo, Débora Martín-García, F. Javier Álvarez and Francisco Herrera-Gómez
Int. J. Environ. Res. Public Health 2020, 17(24), 9360; https://doi.org/10.3390/ijerph17249360 - 14 Dec 2020
Cited by 10 | Viewed by 2581
Abstract
The first wave of the COVID-19 pandemic collapsed the hospitals in Castile and Leon (Spain). An analysis of the clinical characteristics, drug therapies and principal outcome predictors in the COVID-19 hospitalized patients from 1 March to 31 May 2020 is presented through a [...] Read more.
The first wave of the COVID-19 pandemic collapsed the hospitals in Castile and Leon (Spain). An analysis of the clinical characteristics, drug therapies and principal outcome predictors in the COVID-19 hospitalized patients from 1 March to 31 May 2020 is presented through a population-based registry study. Hospital stay variables, ventilation mode data and clinical outcomes were observed. In Castile and Leon hospitals, 7307 COVID-19 patients were admitted, with 57.05% being male and a median of 76 years. The mortality rate was 24.43%, with a high incidence of severe acute respiratory syndrome (SARS) (14.03%) and acute kidney injury (AKI) (10.87%). The most used medicines were antibiotics (90.83%), antimalarials (42.63%), steroids (44.37%) and antivirals, such as lopinavir/ritonavir (42.63%). The use of tocilizumab (9.37%) and anti-SIRS (systemic inflammatory response syndrome) medicines (7.34%) were remarkable. Fundamentally, death occurred more likely over 65 years of age (OR: 9.05). In addition, the need for ventilation was associated with a higher probability of death (OR: 3.59), SARS (OR: 5.14) and AKI (OR: 2.31). The drug-use pattern had been modified throughout the COVID-19 first wave. Multiple factors, such as age, gender and the need for mechanical ventilation, were related to the worst evolution prognosis of the disease. Full article
(This article belongs to the Special Issue COVID-19: Prevention, Diagnosis, Therapy and Follow Up)
Show Figures

Figure 1

16 pages, 7811 KiB  
Article
International Prevalence and Correlates of Psychological Stress during the Global COVID-19 Pandemic
by Maheen M. Adamson, Angela Phillips, Srija Seenivasan, Julian Martinez, Harlene Grewal, Xiaojian Kang, John Coetzee, Ines Luttenbacher, Ashley Jester, Odette A. Harris and David Spiegel
Int. J. Environ. Res. Public Health 2020, 17(24), 9248; https://doi.org/10.3390/ijerph17249248 - 10 Dec 2020
Cited by 45 | Viewed by 5473
Abstract
This study reports perceived stress and associated sociodemographic factors from an international sample of adults, during the COVID-19 pandemic. The Perceived Stress Scale (PSS-10) along with socio-demographic questions were conducted between 8 April 2020 and 11 May 2020. The survey was translated from [...] Read more.
This study reports perceived stress and associated sociodemographic factors from an international sample of adults, during the COVID-19 pandemic. The Perceived Stress Scale (PSS-10) along with socio-demographic questions were conducted between 8 April 2020 and 11 May 2020. The survey was translated from English into five languages. Recruitment was conducted worldwide using social media. A total of 1685 survey responses were collected across 57 countries with eleven countries (≥30 responses/country) included in the sub-analyses. Overall, the mean PSS-10 score was 19.08 (SD = 7.17), reflecting moderate stress compared to previously reported norms. Female gender was associated with a higher PSS score (3.03, p < 0.05) as well as four-year degree holders (3.29, p < 0.05), while adults over 75 years (−7.46, p < 0.05) had lower PSS scores. Personal care composite score (including hours of sleep, exercise, and meditation) was associated with lower PSS scores (−0.39, p < 0.01). Increases in personal care and changes in work expectations were associated with lower PSS scores (−1.30 (p < 0.05) and −0.38 (p < 0.01), respectively). Lower total PSS scores were reported in Germany (−4.82, p < 0.01) compared to the global response sample mean. This information, collected during the initial period of global mitigation orders, provides insight into potential mental health risks and protective factors during crises. Full article
(This article belongs to the Special Issue COVID-19: Prevention, Diagnosis, Therapy and Follow Up)
Show Figures

Figure 1

15 pages, 1201 KiB  
Article
Trading Health for Wealth: The Effect of COVID-19 Response Stringency
by Megan Cross, Shu-Kay Ng and Paul Scuffham
Int. J. Environ. Res. Public Health 2020, 17(23), 8725; https://doi.org/10.3390/ijerph17238725 - 24 Nov 2020
Cited by 34 | Viewed by 4402
Abstract
International governments’ COVID-19 responses must balance human and economic health. Beyond slowing viral transmission, strict lockdowns have severe economic consequences. This work investigated response stringency, quantified by the Oxford COVID-19 Government Response Tracker’s Stringency Index, and examined how restrictive interventions affected infection rates [...] Read more.
International governments’ COVID-19 responses must balance human and economic health. Beyond slowing viral transmission, strict lockdowns have severe economic consequences. This work investigated response stringency, quantified by the Oxford COVID-19 Government Response Tracker’s Stringency Index, and examined how restrictive interventions affected infection rates and gross domestic product (GDP) in China and OECD countries. Accounting for response timing, China imposed the most stringent restrictions, while Sweden and Japan were the least stringent. Expected GDP declines range from −8% (Japan) to −15.4% (UK). While greater restrictions generally slowed viral transmission, they failed to reach statistical significance and reduced GDP (p = 0.006). Timing was fundamental: governments who responded to the pandemic faster saw greater reductions in viral transmission (p = 0.013), but worse decreases in GDP (p = 0.044). Thus, response stringency has a greater effect on GDP than infection rates, which are instead affected by the timing of COVID-19 interventions. Attempts to mitigate economic impacts by delaying restrictions or decreasing stringency may buoy GDP in the short term but increase infection rates, the longer-term economic consequences of which are not yet fully understood. As highly restrictive interventions were successful in some but not all countries, decision-makers must consider whether their strategies are appropriate for the country on health and economic grounds. Full article
(This article belongs to the Special Issue COVID-19: Prevention, Diagnosis, Therapy and Follow Up)
Show Figures

Figure 1

9 pages, 607 KiB  
Article
Simple, Low-Cost and Long-Lasting Film for Virus Inactivation Using Avian Coronavirus Model as Challenge
by Luiz Alberto Colnago, Iara Maria Trevisol, Daiane Voss Rech, Lucimara Aparecida Forato, Cirlei Igreja do Nascimento Mitre, José Paulo Gagliardi Leite, Rodrigo Giglioti and Cintia Hiromi Okino
Int. J. Environ. Res. Public Health 2020, 17(18), 6456; https://doi.org/10.3390/ijerph17186456 - 04 Sep 2020
Cited by 6 | Viewed by 2403
Abstract
The COVID-19 infection, caused by SARS-CoV-2, is inequitably distributed and more lethal among populations with lower socioeconomic status. Direct contact with contaminated surfaces has been among the virus sources, as it remains infective up to days. Several disinfectants have been shown to inactivate [...] Read more.
The COVID-19 infection, caused by SARS-CoV-2, is inequitably distributed and more lethal among populations with lower socioeconomic status. Direct contact with contaminated surfaces has been among the virus sources, as it remains infective up to days. Several disinfectants have been shown to inactivate SARS-CoV-2, but they rapidly evaporate, are flammable or toxic and may be scarce or inexistent for vulnerable populations. Therefore, we are proposing simple, easy to prepare, low-cost and efficient antiviral films, made with a widely available dishwashing detergent, which can be spread on hands and inanimate surfaces and is expected to maintain virucidal activity for longer periods than the current sanitizers. Avian coronavirus (ACoV) was used as model of the challenge to test the antivirus efficacy of the proposed films. Polystyrene petri dishes were covered with a thin layer of detergent formula. After drying, the films were exposed to different virus doses for 10 min and virus infectivity was determined using embryonated chicken eggs, and RNA virus quantification in allantoic fluids by RT-qPCR. The films inactivated the ACoV (ranging from 103.7 to 106.7 EID50), which is chemically and morphologically similar to SARS-CoV-2, and may constitute an excellent alternative to minimize the spread of COVID-19. Full article
(This article belongs to the Special Issue COVID-19: Prevention, Diagnosis, Therapy and Follow Up)
Show Figures

Figure 1

13 pages, 463 KiB  
Article
Characterization of Home Working Population during COVID-19 Emergency: A Cross-Sectional Analysis
by Antimo Moretti, Fabrizio Menna, Milena Aulicino, Marco Paoletta, Sara Liguori and Giovanni Iolascon
Int. J. Environ. Res. Public Health 2020, 17(17), 6284; https://doi.org/10.3390/ijerph17176284 - 28 Aug 2020
Cited by 167 | Viewed by 21880
Abstract
Evidence about the characterization of home workers in terms of both work-related outcomes and health issues is lacking. The purpose of this cross-sectional study was to examine the impact of home working on perceived job productivity and satisfaction, work-related stress, and musculoskeletal (MSK) [...] Read more.
Evidence about the characterization of home workers in terms of both work-related outcomes and health issues is lacking. The purpose of this cross-sectional study was to examine the impact of home working on perceived job productivity and satisfaction, work-related stress, and musculoskeletal (MSK) issues. We included 51 mobile workers, collecting data about demographic characteristics, working experience, job productivity, and stress. Job satisfaction was assessed through the Utrecht Work Engagement Scale (UWES), while MSK pain was investigated by the Brief Pain Inventory (BPI) and Fear Avoidance Beliefs Questionnaire (FABQ). Moreover, a home workplace analysis had to be carried out according to current Italian regulations. Participants declared that they were less productive (39.2%) but less stressed (39.2%) and equally satisfied (51%) compared to the time of office working. Regarding MSK disorders, low back pain (LBP) was referred by 41.2% of home workers and neck pain by 23.5% of them. Neck pain worsened in 50% of home workers, while LBP did not exacerbate in 47.6% of cases. Home workers with MSK pain reported a lower job satisfaction. Depending on our data, the home environment seems to be not adequate in the mobile worker population, with an increased risk for mental health and MSK problems, particularly affecting the spine. Addressing these issues can significantly reduce risks for health, thus, improving job productivity and satisfaction and reducing cost. Full article
(This article belongs to the Special Issue COVID-19: Prevention, Diagnosis, Therapy and Follow Up)
Show Figures

Figure 1

19 pages, 2313 KiB  
Article
A Look Behind the Scenes at COVID-19: National Strategies of Infection Control and Their Impact on Mortality
by Samir Haj Bloukh, Zehra Edis, Annis A. Shaikh and Habib M. Pathan
Int. J. Environ. Res. Public Health 2020, 17(15), 5616; https://doi.org/10.3390/ijerph17155616 - 04 Aug 2020
Cited by 18 | Viewed by 4491
Abstract
(1) Background: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) began spreading across the globe in December and, as of 9 July 2020, had inflicted more than 550,000 deaths. Public health measures implemented to control the outbreak caused socio-economic havoc in many countries. [...] Read more.
(1) Background: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) began spreading across the globe in December and, as of 9 July 2020, had inflicted more than 550,000 deaths. Public health measures implemented to control the outbreak caused socio-economic havoc in many countries. The pandemic highlighted the quality of health care systems, responses of policymakers in harmony with the population, and socio-economic resilience factors. We suggest that different national strategies had an impact on mortality and case count. (2) Methods: We collected fatality data for 17 countries until 2 June 2020 from public data and associated these with implemented containment measures. (3) Results: The outcomes present the effectiveness of control mechanisms in mitigating the virus for selected countries and the UAE as a special case. Pre-existing conditions defined the needed public health strategies and fatality numbers. Other pre-existing conditions, such as temperature, humidity, median age, and low serum 25-hydroxyvitamin D (25(OH)D) concentrations played minor roles and may have had no direct impact on fatality rates. (4) Conclusions: Prevention, fast containment, adequate public health strategies, and importance of indoor environments were determining factors in mitigating the pandemic. Development of public health strategies adapted to pre-existing conditions for each country and community compliance with implemented policies ensure the successful control of pandemics. Full article
(This article belongs to the Special Issue COVID-19: Prevention, Diagnosis, Therapy and Follow Up)
Show Figures

Graphical abstract

20 pages, 2492 KiB  
Article
BCG Vaccination and Mortality of COVID-19 across 173 Countries: An Ecological Study
by Mitsuyoshi Urashima, Katharina Otani, Yasutaka Hasegawa and Taisuke Akutsu
Int. J. Environ. Res. Public Health 2020, 17(15), 5589; https://doi.org/10.3390/ijerph17155589 - 03 Aug 2020
Cited by 39 | Viewed by 13383
Abstract
Ecological studies have suggested fewer COVID-19 morbidities and mortalities in Bacillus Calmette–Guérin (BCG)-vaccinated countries than BCG-non-vaccinated countries. However, these studies obtained data during the early phase of the pandemic and did not adjust for potential confounders, including PCR-test numbers per population (PCR-tests). Currently—more [...] Read more.
Ecological studies have suggested fewer COVID-19 morbidities and mortalities in Bacillus Calmette–Guérin (BCG)-vaccinated countries than BCG-non-vaccinated countries. However, these studies obtained data during the early phase of the pandemic and did not adjust for potential confounders, including PCR-test numbers per population (PCR-tests). Currently—more than four months after declaration of the pandemic—the BCG-hypothesis needs reexamining. An ecological study was conducted by obtaining data of 61 factors in 173 countries, including BCG vaccine coverage (%), using morbidity and mortality as outcomes, obtained from open resources. ‘Urban population (%)’ and ‘insufficient physical activity (%)’ in each country was positively associated with morbidity, but not mortality, after adjustment for PCR-tests. On the other hand, recent BCG vaccine coverage (%) was negatively associated with mortality, but not morbidity, even with adjustment for percentage of the population ≥ 60 years of age, morbidity, PCR-tests and other factors. The results of this study generated a hypothesis that a national BCG vaccination program seems to be associated with reduced mortality of COVID-19, although this needs to be further examined and proved by randomized clinical trials. Full article
(This article belongs to the Special Issue COVID-19: Prevention, Diagnosis, Therapy and Follow Up)
Show Figures

Figure 1

8 pages, 298 KiB  
Article
Experiential Learning Program to Strengthen Self-Reflection and Critical Thinking in Freshmen Nursing Students during COVID-19: A Quasi-Experimental Study
by Yi-Chuan Cheng, Li-Chi Huang, Chi-Hsuan Yang and Hsing-Chi Chang
Int. J. Environ. Res. Public Health 2020, 17(15), 5442; https://doi.org/10.3390/ijerph17155442 - 28 Jul 2020
Cited by 21 | Viewed by 9080
Abstract
This article focuses on the unique needs and concerns of nursing educators and nursing students in the face of the COVID-19 pandemic. During social distancing, interacting with other human beings has been restricted. This would undermine the experiential learning of nursing students. Hence, [...] Read more.
This article focuses on the unique needs and concerns of nursing educators and nursing students in the face of the COVID-19 pandemic. During social distancing, interacting with other human beings has been restricted. This would undermine the experiential learning of nursing students. Hence, it is important to develop and evaluate an experiential learning program (ELP) for nursing education. A pre-test and post-test design were used. The study was conducted in a university in Central Taiwan. A total of 103 nursing students participated in the study from February to June 2019. The study intervention was the experiential learning program (ELP), including bodily experiences and nursing activities with babies, pregnant women, and the elderly. After the intervention, the students completed the self-reflection and insight scale (SRIS) and Taiwan Critical Thinking Disposition Inventory (TCTDI) as outcome measures. An independent t-test showed that there was a significant difference between pre-test and post-test in both SRIS and TCTDI (p < 0.01). The Pearson product–moment correlation analysis showed that SRIS and TCTDI were significantly positively correlated (p < 0.01). ELP has a significant impact on the self-reflection and critical thinking of first-year nursing students, which can be used as a reference for the education of nursing students. During these turbulent times, it is especially vital for faculties to provide experiential learning instead of the traditional teaching concept. Full article
(This article belongs to the Special Issue COVID-19: Prevention, Diagnosis, Therapy and Follow Up)

Review

Jump to: Editorial, Research

12 pages, 1356 KiB  
Review
Veno-Venous Extracorporeal Membrane Oxygenation in COVID-19—Where Are We Now?
by Zbigniew Putowski, Anna Szczepańska, Marcelina Czok and Łukasz J. Krzych
Int. J. Environ. Res. Public Health 2021, 18(3), 1173; https://doi.org/10.3390/ijerph18031173 - 28 Jan 2021
Cited by 4 | Viewed by 3928
Abstract
The recent development in extracorporeal life support (ECLS) has created new therapeutic opportunities for critically ill patients. An interest in extracorporeal membrane oxygenation (ECMO), the pinnacle of ECLS techniques, has recently increased, as for the last decade, we have observed improvements in the [...] Read more.
The recent development in extracorporeal life support (ECLS) has created new therapeutic opportunities for critically ill patients. An interest in extracorporeal membrane oxygenation (ECMO), the pinnacle of ECLS techniques, has recently increased, as for the last decade, we have observed improvements in the survival of patients suffering from severe acute respiratory distress syndrome (ARDS) while on ECMO. Although there is a paucity of conclusive data from clinical research regarding extracorporeal oxygenation in COVID-19 patients, the pathophysiology of the disease makes veno-venous ECMO a promising option. Full article
(This article belongs to the Special Issue COVID-19: Prevention, Diagnosis, Therapy and Follow Up)
Show Figures

Figure 1

16 pages, 13564 KiB  
Review
The History, Efficacy, and Safety of Potential Therapeutics: A Narrative Overview of the Complex Life of COVID-19
by Farah Daou, Gretta Abou-Sleymane, Danielle A. Badro, Nagham Khanafer, Mansour Tobaiqy and Achraf Al Faraj
Int. J. Environ. Res. Public Health 2021, 18(3), 955; https://doi.org/10.3390/ijerph18030955 - 22 Jan 2021
Cited by 5 | Viewed by 4531
Abstract
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic posed a serious public health concern and started a race against time for researchers to discover an effective and safe therapy for coronavirus disease 2019 (COVID-19), the disease caused by SARS-CoV-2. This review aims [...] Read more.
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic posed a serious public health concern and started a race against time for researchers to discover an effective and safe therapy for coronavirus disease 2019 (COVID-19), the disease caused by SARS-CoV-2. This review aims to describe the history, efficacy, and safety of five potential therapeutics for COVID-19, remdesivir, favipiravir, hydroxychloroquine, tocilizumab, and convalescent plasma. A literature review was conducted through October 2020 to identify published studies evaluating the efficacy and safety of these five potential therapeutics. Clinical improvement was used to assess the efficacy, while reported withdrawals from study participation and adverse events were used to evaluate the safety. In total, 95 clinical studies (6 interventional and 89 observational studies) were obtained, of which 42 were included in this review. The evaluation of the efficacy and safety profiles is challenging due to the limitations of the clinical studies on one hand, and the limited number of randomized controlled trials (RCTs) on the other. Moreover, there was insufficient evidence to support repurposing remdesivir, favipiravir, and tocilizumab for COVID-19. Full article
(This article belongs to the Special Issue COVID-19: Prevention, Diagnosis, Therapy and Follow Up)
Show Figures

Figure 1

7 pages, 1009 KiB  
Review
State of Fragility Fractures Management during the COVID-19 Pandemic
by Umberto Tarantino, Ida Cariati, Virginia Tancredi, Donato Casamassima, Eleonora Piccirilli, Riccardo Iundusi and Elena Gasbarra
Int. J. Environ. Res. Public Health 2020, 17(21), 7732; https://doi.org/10.3390/ijerph17217732 - 22 Oct 2020
Cited by 14 | Viewed by 3861
Abstract
Osteoporosis is a public health concern all over the world. As a chronic condition, it generally requires prolonged medical interventions to limit the risks of further bone loss, impaired skeletal integrity and the onset of fractures. This problem is further complicated by the [...] Read more.
Osteoporosis is a public health concern all over the world. As a chronic condition, it generally requires prolonged medical interventions to limit the risks of further bone loss, impaired skeletal integrity and the onset of fractures. This problem is further complicated by the fact that the abrupt cessation of some therapies may be associated with an increased risk of harm. It is in this context that the COVID-19 pandemic has caused an unprecedented disruption to the provision of healthcare worldwide, exceeding our worst expectations in terms of the number of lives lost and the rapidity at which consolidated economies and healthcare systems are being significantly damaged. In this review, we assessed the challenges and strategies used in the management of osteoporosis and fragility fracture care during the COVID-19 pandemic. We also examined the available evidence and provided clinical recommendations that will require reassessment as the worldwide response to COVID-19 evolves. Full article
(This article belongs to the Special Issue COVID-19: Prevention, Diagnosis, Therapy and Follow Up)
Show Figures

Figure 1

11 pages, 634 KiB  
Review
Clinical Presentation of COVID-19: Case Series and Review of the Literature
by Margherita Macera, Giulia De Angelis, Caterina Sagnelli, Nicola Coppola and Vanvitelli COVID-19 Group
Int. J. Environ. Res. Public Health 2020, 17(14), 5062; https://doi.org/10.3390/ijerph17145062 - 14 Jul 2020
Cited by 54 | Viewed by 8994
Abstract
COVID-19 infection has a broad spectrum of severity ranging from an asymptomatic form to a severe acute respiratory syndrome that requires mechanical ventilation. Starting with the description of our case series, we evaluated the clinical presentation and evolution of COVID-19. This article is [...] Read more.
COVID-19 infection has a broad spectrum of severity ranging from an asymptomatic form to a severe acute respiratory syndrome that requires mechanical ventilation. Starting with the description of our case series, we evaluated the clinical presentation and evolution of COVID-19. This article is addressed particularly to physicians caring for patients with COVID-19 in their clinical practice. The intent is to identify the subjects in whom the infection is most likely to evolve and the best methods of management in the early phase of infection to determine which patients should be hospitalized and which could be monitored at home. Asymptomatic patients should be followed to evaluate the appearance of symptoms. Patients with mild symptoms lasting more than a week, and without evidence of pneumonia, can be managed at home. Patients with evidence of pulmonary involvement, especially in patients over 60 years of age, and/or with a comorbidity, and/or with the presence of severe extrapulmonary manifestations, should be admitted to a hospital for careful clinical-laboratory monitoring. Full article
(This article belongs to the Special Issue COVID-19: Prevention, Diagnosis, Therapy and Follow Up)
Show Figures

Figure 1

Back to TopTop